(Q51617077)

8 April 2018

title

An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizide. (English)

1 reference

8 April 2018

author name string

Jaber LA

1

1 reference

8 April 2018

Wenzloff NJ

2

1 reference

8 April 2018

Komanicky P

3

1 reference

8 April 2018

Antal EJ

4

1 reference

8 April 2018

publication date

1 February 1990

1 reference

8 April 2018

The Journal of Clinical Pharmacology

published in

1 reference

8 April 2018

volume

30

1 reference

8 April 2018

issue

2

1 reference

8 April 2018

page(s)

181-188

1 reference

8 April 2018

The pharmacology of sulfonylureas

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Pharmacokinetics of glyburide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Stability of Reacted Chemstrip bG

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Effects of oral sulfonylureas on the spectrum of defects in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Monitoring metabolic control in diabetic outpatients with glycosylated hemoglobin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Effect of glipizide treatment on various aspects of glucose, insulin, and lipid metabolism in patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03460.X

10.1002/J.1552-4604.1990.TB03460.X

21 January 2018

Identifiers

DOI

1 reference

8 April 2018

1 reference

8 April 2018